TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/28/19 19:10 | 5/24/19 | BSTC | Biospecifics Technologies Corp | DE | Health | Drug | Pharmaceutical Preparations | Wegman Mark N | NY | D | S | -477 | 61.09 | 0 | -8 | -11 | 65 | D | |||||||||||||||
5/23/19 17:13 | 5/22/19 | BSTC | Biospecifics Technologies Corp | DE | Health | Drug | Pharmaceutical Preparations | Wegman Mark N | NY | D | S | -76 | 63.70 | 0 | -1 | -2 | 73 | D | |||||||||||||||
5/22/19 14:51 | 5/21/19 | BSTC | Biospecifics Technologies Corp | DE | Health | Drug | Pharmaceutical Preparations | Wegman Mark N | NY | D | S | -384 | 64.04 | 0 | -6 | -7 | 74 | D | |||||||||||||||
5/17/19 17:47 | 5/15/19 | BSTC | Biospecifics Technologies Corp | DE | Health | Drug | Pharmaceutical Preparations | Wegman Mark N | NY | D | M.d | 314 | 20.95 | 0 | 15 | 23 | 80 | D | |||||||||||||||
9/11/18 21:23 | 9/10/18 | BSTC | Biospecifics Technologies Corp | DE | Health | Drug | Pharmaceutical Preparations | Wegman Mark N | NY | D | S.m | -374 | 57.52 | 0 | -7 | -9 | 65 | D | |||||||||||||||
8/23/18 20:36 | 8/22/18 | BSTC | Biospecifics Technologies Corp | DE | Health | Drug | Pharmaceutical Preparations | Wegman Mark N | NY | D | S.m | -447 | 52.63 | 0 | -9 | -11 | 72 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |